Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on Oct 06, 2016 12:10pm
367 Views
Post# 25317575

Another email from Fred on reason for choice of Nov 21

Another email from Fred on reason for choice of Nov 21The date is pretty much firmed up for Nov 21. We are finalizing the location for the event in NY as we speak and will soon start sending out the invitations. At that point, we will of course publicly disclose all that information. There are many reasons why we could not find a date that worked for all involved in October (Last week of October is earnings season start for large cap followed by mid cap the first week of November, we also have to get all the senior executives of PLI in the same room at the same time, a very difficult task when you look at all the conferences we are presenting posters at (ASN, AHA etc…). There are also Investment bankers conferences to take under consideration. We went through all the possibilities and the only date that could work was the 21 before the US thanksgiving break. Investors should not read anything into this other than it is a logistic nightmare trying to find a date that works for all involved…simple as that and no hidden meaning at all.

Feel free to post my response as you see fit.

Best,

Fred

Frdric Dumais, B. Comm., LLB.

Directeur principal, Communications et relations avec les investisseurs
Senior Director, Communications and Investor Relations

ProMetic Sciences de la Vie inc.
ProMetic Life Sciences Inc.

440 boul. Armand-Frappier, bureau (suite) 300
Laval, Qubec, Canada
H7V 4B4
Tel. : 450-781-0115
Fax : 450-781-4477
Mobile : 514-261-4735
f.dumais@prometic.com
www.prometic.com
Bullboard Posts